MIRM
Mirum Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $2.15B | Price | $72.65 |
| Volume | 389.71K | Change | +0.62% |
| P/E Ratio | -24.4 | Open | $71.96 |
| Revenue | $336.9M | Prev Close | $72.20 |
| Net Income | $-87.9M | 52W Range | $36.88 - $78.54 |
| Div Yield | N/A | Target | $83.55 |
| Overall | 54 | Value | 40 |
| Quality | 63 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyMirum Pharmaceuticals Inc. (MIRM) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $72.65 with a market capitalization of $2.15 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating solid quality metrics with a MarketXLS quality score of 63.
Today's trading session shows MIRM with a volume of 390K shares. The stock opened down 0.33% from yesterday's close of $72.20. Current analyst estimates project earnings of $-0.67 per share for this year, with next year targeting $0.04.
MIRM demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for MIRM include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 15.0%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MIRM | $72.65 | +0.6% | 389.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mirum Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW